109 related articles for article (PubMed ID: 3497914)
21. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
Sanders CC; Sanders WE
J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
[TBL] [Abstract][Full Text] [Related]
22. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp.
Lindh E; Dornbusch K; Jalakas K; Forsgren A
APMIS; 1990 May; 98(5):462-70. PubMed ID: 2162681
[TBL] [Abstract][Full Text] [Related]
23. Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
Lupiola-Gómez PA; González-Lama Z; Tejedor-Junco MT; González-Martín M; Martín-Barrasa JL
Can J Microbiol; 2003 Mar; 49(3):207-15. PubMed ID: 12795407
[TBL] [Abstract][Full Text] [Related]
24. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
[TBL] [Abstract][Full Text] [Related]
25. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.
Stark C; Edlund C; Hedberg M; Nord CE
Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):18-24. PubMed ID: 7729448
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
Vuye A
Chemotherapy; 1982; 28(4):267-75. PubMed ID: 6981493
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of stably derepressed beta-lactamase producing strains to imipenem and four quinolones.
Jones RN; Barry AL
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):82-3. PubMed ID: 3132387
[No Abstract] [Full Text] [Related]
28. Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.
Livermore DM
Eur J Clin Microbiol; 1987 Aug; 6(4):439-45. PubMed ID: 3311738
[TBL] [Abstract][Full Text] [Related]
29. Influence of imipenem on the serum resistance of enterobacteriaceae.
Wiemer CW; Kubens B; Opferkuch W
Rev Infect Dis; 1985; 7 Suppl 3():S426-31. PubMed ID: 3863217
[TBL] [Abstract][Full Text] [Related]
30. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
Miller MA; Finan M; Yousuf M
J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337
[TBL] [Abstract][Full Text] [Related]
31. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Moritz VA; Carson PB
J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
[TBL] [Abstract][Full Text] [Related]
32. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.
Ott JL; Turner JR; Mahoney DF
Antimicrob Agents Chemother; 1979 Jan; 15(1):14-9. PubMed ID: 311615
[TBL] [Abstract][Full Text] [Related]
33. Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamases.
Sanders CC; Sanders WE; Thomson KS; Iaconis JP
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():187-96. PubMed ID: 2808207
[TBL] [Abstract][Full Text] [Related]
34. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
35. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
[TBL] [Abstract][Full Text] [Related]
36. Association of halogenated isoxazolylpenicillins with penicillinase-sensitive beta-lactam antibiotics. Microbiological evaluation on beta-lactamase-producing Enterobacteriaceae.
Ravagnan G; Nicoletti M; Renzini G; Strom R
Chemotherapy; 1977; 23(3):159-66. PubMed ID: 837773
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
Bujdáková H; Kallová J; Lausová A; Kettner M
Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
[TBL] [Abstract][Full Text] [Related]
38. Interactions of meropenem with class I chromosomal beta-lactamases.
Yang YJ; Livermore DM
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():207-17. PubMed ID: 2808208
[TBL] [Abstract][Full Text] [Related]
39. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
Hashizume T; Yamaguchi A; Sawai T
J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
[No Abstract] [Full Text] [Related]
40. Properties of spontaneous Enterobacter cloacae mutants with temperature-conditional derepression of type I beta-lactamase synthesis.
Curtis NA; East SJ; Cornford RJ; Walker LA
J Antimicrob Chemother; 1987 Apr; 19(4):417-27. PubMed ID: 3495528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
